Measles outbreaks in the US are the result of choice. To get vaccinated or not. But there’s another vaccine-preventable disease that’s making a global comeback—whooping cough or pertussis.
How GSK and Sanofi won the whooping cough vaccination war
Whooping cough is facing a global resurgence which has been linked to the second generation vaccine manufactured by GSK and Sanofi. Despite this, GSK and Sanofi’s vaccine rules the Indian private market
Incidence of whooping cough has been on the rise in developed countries for years now, and India is seeing the same
The resurgence is linked to second generation vaccines whose efficacy wanes faster than that of older vaccines
In India, the public market uses the older vaccine, but the second generation vaccines rule the private market
While the Indian Academy of Pediatrics advocated against the newer vaccines in 2013, it allowed for them again in 2018